Research On The Development Strategy Of Youlin (China) Biological Pharmaceutical Co., Ltd.

In recent years, with the social and economic development of different countries in the world, the morbidity of diabetes has been increasing year on year, becoming a major social problem that threats people's health and draws attention from governments, health departments and medical workers of all countries. There are 92 million diabetics as well as 148 million pre-diabetics or diabetes reservists in China. The high morbidity of diabetes determines the rigid demand of Chinese people for diabetes drugs. After China's entry into the WTO, drug tariffs have reduced gradually. The government has implemented supporting policies for originally researched drugs and the medical drug market has opened up progressively. Multinational pharmaceutical giants with tremendous strength and patented products and technologies have mounted massive attack to the Chinese biological drug market, and domestic biopharmaceutical companies have imitated biological drugs whose patents have expired for generous profits, leading to increasingly fierce market competition in biological drugs, especially diabetes drugs. How to overcome all sorts of difficulties to accomplish sustained development is a problem to be faced and solved by every foreign-invested biopharmaceutical company, making it necessary for every enterprise to work out a set of scientific, correct and implementable corporate strategies.This paper takes Youlin(China) Biological Pharmaceutical Co., Ltd. (Youlin) as the object of study, integrates the theory of corporate strategic management, uses the method of corporate strategic analysis and optimization, maps out and evaluates corporate strategies, implements and controls strategies step by step, and conducts systematic guidance on Youlin's development in the coming three years.Part I elaborates the development process of the theory of corporate strategic management, content of all stages and core ideology; Part II applies theoretical knowledge of corporate strategic management to analyze Youlin's internal environment, and deduces its strategic orientation from the actualities and development trends of the biopharmaceutical industry and the external environment of Youlin; Part III maps out Youlin's strategic situation and overall strategy based on the results of foregoing analysis, and defines functional strategies in such aspects as characteristic marketing, human resources and finance; the final part comes up with specific and detailed measures for implementing and controlling Youlin's development strategy in China.The research results of this paper are of great guiding significance for how to map out Youlin's future development strategies and accomplish stable and sustained development, and are also instructive for its counterparts in the industry.